Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only

被引：12
|
作者：
Jobsen, Jan J. [1 ]
ten Cate, Lambert Naudin [2 ]
Lybeert, Marnix L. M. [3 ]
Scholten, Astrid [4 ]
van der Steen-Banasik, Elzbieta M. [5 ,6 ,7 ]
van der Palen, Job
Kroese, Marika C. Stenfert [8 ]
Slot, Annerie [9 ]
Schutter, Eltjo M. J. [10 ]
Siesling, Sabine [11 ]
机构：
[1] Med Spectrum Twente, Dept Radiat Oncol, Haaksbergerstr 55, NL-7513 ER Enschede, Netherlands
[2] Lab Pathol Oost Nederland, NL-7512 ER Enschede, Netherlands
[3] Catharina Hosp, Dept Radiat Oncol, Eindhoven, Netherlands
[4] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2333 ZA Leiden, Netherlands
[5] Arnhem Radiotherapeut Inst, Arnhem, Netherlands
[6] Univ Twente, Fac Behav Sci, Dept Res Methodol Measurement & Data Anal, NL-7500 AE Enschede, Netherlands
[7] Med Spectrum Twente, Dept Clin Epidemiol, NL-7513 ER Enschede, Netherlands
[8] Radiotherapy Inst Steden Omstreken, Deventer, Netherlands
[9] Radiotherapy Inst Friesland, Leeuwarden, Netherlands
[10] Med Spectrum Twente, Dept Obstet & Gynaecol, NL-7513 ER Enschede, Netherlands
[11] Comprehens Canc Ctr North East, Enschede, Netherlands
来源：
OBSTETRICS AND GYNECOLOGY INTERNATIONAL | 2011年 / 2011卷
关键词：
D O I：
10.1155/2011/962518
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P =.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P =.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Rios-Doria, Eric
    Abu-Rustum, Nadeem
    Glaser, Gretchen
    McGree, Michaela
    Eriksson, Ane Gerda Z.
    Pham, Melissa
    Soliman, Pamela
    Ataseven, Beyhan
    Alektiar, Kaled
    Zamarin, Dmitriy
    Leitao, Mario
    Mueller, Jennifer
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S265 - S266
  • [2] 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both
    Rios-Doria, Eric
    Abu-Rustum, Nadeem R.
    Glaser, Gretchen
    Mcgree, Michaela
    Eriksson, Ane Gerda
    Pham, Melissa
    Soliman, Pamela
    Ataseven, Beyhan
    Alektiar, Kaled
    Zamarin, Dmitriy
    Leitao, Mario L., Jr.
    Mueller, Jennifer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [3] The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer
    Havrilesky, Laura J.
    Cragun, Janiel M.
    Calingaert, Brian
    Secord, Angeles Alvarez
    Valea, Fidel A.
    Clarke-Pearson, Daniel L.
    Berchuck, Andrew
    Soper, John T.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 401 - 405
  • [4] Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA
    Dinoi, Giorgia
    Lorusso, Domenica
    La Fera, Eleonora
    Restaino, Stefano
    Pafundi, Pia Clara
    Gioe, Alessandro
    Naccarato, Laura
    Palmieri, Emilia
    Musacchio, Lucia
    Di Stefano, Ettore
    Tarantino, Vincenzo
    Scambia, Giovanni
    Fanfani, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [5] The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer
    Preyer, O
    Obermair, A
    Formann, E
    Schmid, W
    Perrin, LC
    Ward, BG
    Crandon, AJ
    Nicklin, JL
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 269 - 273
  • [6] Positive Adnexal or Uterine Serosal Involvement in Stage IIIC Endometrial Cancer Is an Adverse Factor for Recurrence
    Hetu, Valerie
    Petignat, Patrick
    Wu, Yucan
    Drouin, Pierre
    Sauthier, Philippe
    Provencher, Diane
    Gauthier, Philippe
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2009, 67 (03) : 173 - 177
  • [7] Stage IIIA endometrial carcinoma: Outcome and predictors of survival
    Bansal, S.
    Buck, A. M.
    Herzog, T. J.
    Burke, W. M.
    Schiff, P. B.
    Wright, J. D.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S88 - S89
  • [8] Stage IIIA Endometrial Carcinoma Outcome and Predictors of Survival
    Bansal, Sharmilee
    Buck, Adam M.
    Herzog, Thomas J.
    Deutsch, Israel
    Burke, William M.
    Wright, Jason D.
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (01): : 100 - 105
  • [9] Assessment of prognostic factors in stage IIIA endometrial cancer
    Mariani, A
    Webb, MJ
    Keeney, GL
    Aletti, G
    Podratz, KC
    GYNECOLOGIC ONCOLOGY, 2002, 86 (01) : 38 - 44
  • [10] Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer
    Lum, Marija M.
    Belnap, Thomas W.
    Frandsen, Jonathan
    Brown, Aaron P.
    Sause, William T.
    Soisson, Andrew P.
    Dodson, Mark K.
    Werner, Theresa
    Gaffney, David K.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (03): : 283 - 288
12345